Xeltis AG

Xeltis is a clinical-stage medical device company pioneering a restorative approach in heart valve therapy.

RestoreX, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of heart valve function, through a therapeutic approach called Endogenous Tissue Restoration (ETR).